Related Experiment Video
Updated: Apr 29, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Weight of the bleeding impact on early and late mortality after percutaneous coronary intervention
Gjin Ndrepepa1, Elena Guerra, Stefanie Schulz
1Deutsches Herzzentrum, Lazarettstrasse 36, 80636, Munich, Germany, ndrepepa@dhm.mhn.de.
Insights
Bleeding after percutaneous coronary intervention (PCI) significantly increases early and late mortality risk. While bleeding is the primary driver of 30-day deaths, late mortality is influenced by other cardiovascular risk factors.
Area of Science:
- Cardiology
- Clinical Research
- Patient Outcomes
Background:
- The link between bleeding and mortality following percutaneous coronary intervention (PCI) requires further investigation.
- Understanding this association is crucial for optimizing patient care and reducing adverse events post-PCI.
Purpose of the Study:
- To examine the impact of bleeding on both early (30-day) and late (30-day to 1-year) mortality in patients undergoing PCI.
- To identify bleeding as a predictor of mortality in the context of PCI procedures.
Main Methods:
- A large cohort study of 14,180 patients undergoing PCI.
- Bleeding events were classified using Bleeding Academic Research Consortium (BARC) criteria within 30 days post-PCI.
- Landmark analysis at 1 month was employed to differentiate early and late mortality risks associated with bleeding.
Main Results:
- Patients experiencing bleeding within 30 days had a significantly higher risk of early mortality (adjusted hazard ratio [HR] = 5.00).
- Bleeding also increased the risk of late mortality (30-day to 1-year; adjusted HR = 1.65), though to a lesser extent than early mortality.
- Bleeding was the strongest predictor of 30-day mortality, while age and other cardiovascular risk factors were more dominant in late mortality.
Conclusions:
- Bleeding following PCI is a significant independent risk factor for both early and late mortality.
- The strong association of bleeding with early mortality underscores the need for vigilant monitoring and management of bleeding events.
- While bleeding contributes to late mortality, its impact is partially mediated by the co-occurrence of other cardiovascular risk factors.
Abstract:
The association between bleeding and timing of mortality after percutaneous coronary intervention (PCI) remains poorly investigated. We aimed to investigate the impact of bleeding on early (30-day) and late (30-day to 1 year) mortality after PCI. The study includes 14,180 patients. Bleeding within 30 days after PCI was defined using the Bleeding Academic Research Consortium criteria. Landmark analysis pre-specified at 1 month was performed to assess early and late mortality associated with bleeding. The main outcome was all-cause early and late mortality after PCI. Overall, 414 patients (2.9 %) died within the first year after PCI. Within 30 days after PCI there were 36 deaths among patients with bleeding (n = 1,510) and 44 deaths among patients without bleeding (n = 12,670; Kaplan-Meier [KM] estimates of mortality, 2.4 and 0.3 %; adjusted hazard ratio [HR] = 5.00, 95 % confidence interval 3.16-7.88, P < 0.001). In the 30-day to 1-year period there were 68 deaths among patients with bleeding and 266 deaths among patients without bleeding (KM estimates, 4.7 and 2.1 %; adjusted HR = 1.65 [1.25-2.17], P < 0.001. Bleeding was the strongest correlate of 30-day mortality. The association of bleeding with late mortality was significant but was weaker than that of age, diabetes, C-reactive protein, serum creatinine and platelet count. In conclusion, patients with bleeding after PCI continue to be at higher risk of early and late mortality compared to patients without bleeding. Bleeding was the strongest associate of early mortality whereas the increased risk for late mortality was mostly mediated by cardiovascular risk factors clustered in patients with bleeding.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Peripheral Artery Disease V: Postoperative Nursing Management